Increased safety requirements concerning products of medical technology. new rules make CE labeling compulsory in most cases
Liedström, G.
Lakartidningen 95(35): 3681-3682
1998
ISSN/ISBN: 0023-7205 PMID: 9748783 Document Number: 492066
Document emailed within 1 workday
Related Documents
Nightingale, S.L. 1990: New requirements for tampon labeling American Family Physician 41(3): 999-1000Lafolie, P. 2004: More stringent requirements concerning clinical research. The new EU rules come into effect on May 1 Lakartidningen 101(10): 917-920
Fujimasa, I. 1973: Technics in educational technology in medical education--a new methodology in medical education to meet the needs of modern medical technology Nursing Technique 19(10): S: 90-S: 100
Kornats'kyĭ, V.M. 2000: Medical, social, economic, and legal grounds for compulsory medical insurance in Ukraine Likars'ka Sprava 2000(6): 114-116
Kondo, T. 2004: Proteomics using two-dimensional polyacrylamide gel electrophoresis and fluorescence dye labeling technology Seikagaku. Journal of Japanese Biochemical Society 76(4): 385-390
1999: Minimal requirements for adequate labeling of allergy extracts and skin tests report forms. ACAAI Board of Regents Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 83(3): 201
McDaniel, T.K.; Huang, Y.; Yin, J.; Needleman, S.W.; Meltzer, S.J. 1991: Direct radioactive labeling of unpurified PCR products using Klenow fragment Biotechniques 11(2): 164; 166
Chomyn, A. 1996: In vivo labeling and analysis of human mitochondrial translation products Methods in Enzymology 264: 197-211
1994: For U.S. drug companies' products sold in developing countries, labeling is often inadequate American Journal of Hospital Pharmacy 51(7): 875-876
Bowles, G.C. 1972: F.D.A. to assess O.T.C. drugs for safety, efficacy, labeling Modern Hospital 118(3): 126
Mizukami, S. 2014: Protein labeling technology based on mutant enzyme and its application to new biological research tools Seikagaku. Journal of Japanese Biochemical Society 86(2): 154-159
Sasaki, Y. 1980: Clinico-medical application of stable isotopes -- improvement of medical instruments and trends in the supply of labeling compounds Nihon Rinsho. Japanese Journal of Clinical Medicine 38(11): 4432-4444
Leithoff, H. 1976: Compulsory medical treatment Zfa. Zeitschrift für Allgemeinmedizin 52(20): 1037-1042
Tolou, H.; Martelloni, M.; Durand, J.P. 1994: Rapid control of peptide coupling and labeling reaction products with MALDI, time-of-flight mass spectrometry Peptide Research 7(6): 290-291
Lu, L-yun.; Zhou, S-yuan.; Liu, T.; Qin, E-qi.; Ren, Y-lan.; Li, Y. 2014: Rules for acupoint selection in treatment of perimenopausal syndrome based on data mining technology Zhongguo Zhen Jiu 34(10): 1017-1022
Gaisbauer, G. 1975: Occasional consultations and compulsory medical secrecy Deutsche Medizinische Wochenschrift 100(39)
Zmudzki, J. 2003: Risk analysis rules for the establishing of maximum residue limits of veterinary medicinal products Roczniki Panstwowego Zakladu Higieny 54 Suppl: 12-13
Rampton, A.J.; Mallaiah, S.; Garrett, C.P. 1988: Increased ventilation requirements during obstetric general anaesthesia British Journal of Anaesthesia 61(6): 730-737
Niimi, S. 2015: Development of guidance for the approval process of brand-new medical products and regenerative medicine products Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo Hokoku 133: 1-7
Calmbacher, C.W. 1993: The goal of safety training rules: reducing the threat of injury Occupational Health and Safety 62(3): 80-84